2023 annual financial data
Amphastar Pharmaceuticals 2023 Net income growth
Direct answer
Net income growth was 50.51%.
Operating income was 196,987,000 USD and net income was 137,545,000 USD.
Operating cash flow was 183,503,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 644,395,000 USD
- Operating income
- 196,987,000 USD
- Net income
- 137,545,000 USD
- Operating cash flow
- 183,503,000 USD